Capital raised by Parcel Biosciences
1 Form D filing · first filed Feb 2026 · San Francisco, CA
Director
Listed on Parcel Biosciences's Form D filings
Morgan Cheatham is on file as Director at Parcel Biosciences in San Francisco, CA. Parcel Biosciences has 1 Form D filing on record, $13.2M raised in total.
The STAmP™ platform is a non-viral, nanoparticle-free delivery system for mRNA. It utilizes chemically modified oligonucleotides, called ParcelOligos, which anneal directly to the mRNA payload. This process stabilizes the mRNA and allows for the attachment of targeting ligands (such as GalNAc or C16) to guide the therapeutic to specific cells and tissues.
